-
1
-
-
84855512361
-
Management of hyperglycemia in hospitalized patients in non-critical care setting: An endocrine society clinical practice guideline
-
Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16-38.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 16-38
-
-
Umpierrez, G.E.1
Hellman, R.2
Korytkowski, M.T.3
-
2
-
-
56149122788
-
Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation
-
Derr RL, Hsiao VC, Saudek CD. Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care. 2008;31:1972-1977.
-
(2008)
Diabetes Care
, vol.31
, pp. 1972-1977
-
-
Derr, R.L.1
Hsiao, V.C.2
Saudek, C.D.3
-
3
-
-
34147183373
-
Hyperglycemia and length of stay in patients hospitalized for bone marrow transplantation
-
Garg R, Bhutani H, Alyea E, Pendergrass M. Hyperglycemia and length of stay in patients hospitalized for bone marrow transplantation. Diabetes Care. 2007;30: 993-994.
-
(2007)
Diabetes Care
, vol.30
, pp. 993-994
-
-
Garg, R.1
Bhutani, H.2
Alyea, E.3
Pendergrass, M.4
-
4
-
-
34250809017
-
Sliding scale insulin use: Myth or insanity?
-
Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med. 2007;120:563-567.
-
(2007)
Am J Med
, vol.120
, pp. 563-567
-
-
Umpierrez, G.E.1
Palacio, A.2
Smiley, D.3
-
5
-
-
70449721289
-
Glucocorticoid-induced hyperglycemia
-
Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15:469-474.
-
(2009)
Endocr Pract
, vol.15
, pp. 469-474
-
-
Clore, J.N.1
Thurby-Hay, L.2
-
6
-
-
79951719600
-
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery
-
Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011; 34:256-261.
-
(2011)
Diabetes Care
, vol.34
, pp. 256-261
-
-
Umpierrez, G.E.1
Smiley, D.2
Jacobs, S.3
-
7
-
-
34548417984
-
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial
-
Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30:2181-2186.
-
(2007)
Diabetes Care
, vol.30
, pp. 2181-2186
-
-
Umpierrez, G.E.1
Smiley, D.2
Zisman, A.3
-
8
-
-
67649183171
-
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control
-
Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353-369.
-
(2009)
Endocr Pract
, vol.15
, pp. 353-369
-
-
Moghissi, E.S.1
Korytkowski, M.T.2
Dinardo, M.3
-
9
-
-
1542314287
-
Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate- cytarabine regimen
-
Weiser MA, Cabanillas ME, Konopleva M, et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer. 2004;100:1179-1185.
-
(2004)
Cancer
, vol.100
, pp. 1179-1185
-
-
Weiser, M.A.1
Cabanillas, M.E.2
Konopleva, M.3
-
10
-
-
34250853452
-
Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality
-
Ali NA, O'Brien JM Jr, Blum W, et al. Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer. 2007;110:96-102.
-
(2007)
Cancer
, vol.110
, pp. 96-102
-
-
Ali, N.A.1
O'Brien Jr., J.M.2
Blum, W.3
-
11
-
-
33745319608
-
Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4
-
Ranta F, Avram D, Berchtold S, et al. Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes. 2006;55:1380-1390.
-
(2006)
Diabetes
, vol.55
, pp. 1380-1390
-
-
Ranta, F.1
Avram, D.2
Berchtold, S.3
-
12
-
-
85003195436
-
Cortisol-induced insulin resistance in man: Impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action
-
Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab. 1982;54:131-138.
-
(1982)
J Clin Endocrinol Metab
, vol.54
, pp. 131-138
-
-
Rizza, R.A.1
Mandarino, L.J.2
Gerich, J.E.3
-
13
-
-
0036789252
-
Troglitazone antagonizes metabolic effects of glucocorticoids in humans: Effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin
-
Willi SM, Kennedy A, Wallace P, Ganaway E, Rogers NL, Garvey WT. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin. Diabetes. 2002;51:2895-2902.
-
(2002)
Diabetes
, vol.51
, pp. 2895-2902
-
-
Willi, S.M.1
Kennedy, A.2
Wallace, P.3
Ganaway, E.4
Rogers, N.L.5
Garvey, W.T.6
-
14
-
-
0029911347
-
In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution
-
Coderre L, Vallega GA, Pilch PF, Chipkin SR. In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. Am J Physiol. 1996; 271:E643-E648.
-
(1996)
Am J Physiol
, vol.271
-
-
Coderre, L.1
Vallega, G.A.2
Pilch, P.F.3
Chipkin, S.R.4
-
15
-
-
8944237507
-
High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men
-
Matsumoto K, Yamasaki H, Akazawa S, et al. High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. J Clin Endocrinol Metab. 1996;81:2621-2626.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 2621-2626
-
-
Matsumoto, K.1
Yamasaki, H.2
Akazawa, S.3
-
16
-
-
33750500326
-
Clinical practice. Management of hyperglycemia in the hospital setting
-
Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355: 1903-1911.
-
(2006)
N Engl J Med
, vol.355
, pp. 1903-1911
-
-
Inzucchi, S.E.1
|